Genex Pharmaceutical, Inc.
Genex Pharmaceutical, Inc. (GENX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
genx · pe ratio · data through Dec 31, 2007
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Genex Pharmaceutical, Inc. (GENX) measures how much investors pay for each dollar of the company's trailing earnings. GENX's current PE ratio of 0.01x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.02. −99.9% discount vs 5Y avg 8.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2007-12-31
PE Ratio History
2003 – 2007 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%8.2x
MedianQ3 · 75%15.1x
Max
At 0.01x, GENX's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Genex Pharmaceutical, Inc.You GENX | $0M | 0.01x | — | $0.02 |
 The CannaBusiness Group, Inc. CBGI | $0M | N/A | — | -$1.98 |
 Fiore Cannabis Ltd. FIORF | $0M | N/A | — | -$0.06 |
 Green Growth Brands Inc. GGBXF | $0M | N/A | — | -$0.40 |
 Juva Life Inc. JUVAF | $0M | N/A | — | -$0.06 |
 Legacy Technology Holdings, Inc. LTHO | $0M | N/A | — | -$0.00 |
 Wayland Group Corp. MRRCF | $0M | N/A | — | -$0.75 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2007-12-31Latest FY2007 | 15.11x | $0.02 | +303.1% | |
2006-12-31 FY2006 | 3.75x | $0.03 | -22.8% | |
2005-12-31 FY2005 | 4.85x | $0.04 | -57.6% | |
2004-12-31 FY2004 | 11.45x | $0.06 | — | |
2003-09-30 FY2003 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Genex Pharmaceutical, Inc. (GENX) measures how much investors pay for each dollar of the company's trailing earnings. GENX's current PE ratio of 0.01x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.02.
Frequently asked questions
GENX pe ratio · 6 questionsGENX's current PE ratio is 0.01x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $0.02. Data sourced from Financial Modeling Prep via GENX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Genex Pharmaceutical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09